ALEXANDRIA, Va., July 7 -- United States Patent no. 12,674,167, issued on July 7, was assigned to HiCELL Tech.
"Aptamer specifically binding to cancer stem cells, and use thereof" was invented by Jae Ho Kim (Busan, South Korea) and Dae Kyoung Kim (Yangsan-si, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to aptamers that specifically bind to cancer stem cells. The aptamers according to the present invention specifically bind to cancer stem cells and reduce cell adhesion ability, cell proliferation, drug resistance and cell migration, which are characteristics of cancer stem cells, thus having excellent anticancer effects. Therefore, the aptamer may be used in variou...